Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cabaletta Bio Inc (NQ: CABA )

14.80 -0.13 (-0.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 830,446
Open 14.81
Bid (Size) 14.08 (1)
Ask (Size) 15.33 (1)
Prev. Close 14.93
Today's Range 13.93 - 14.90
52wk Range 0.6350 - 19.34
Shares Outstanding 31,355,723
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cabaletta Bio Receives FDA Clearance of IND Application for Treatment of Systemic Sclerosis with CABA-201
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
From Cabaletta Bio
Via GlobeNewswire

Performance

YTD
+57.45%
+57.45%
1 Month
+7.01%
+7.01%
3 Month
+20.42%
+20.42%
6 Month
+75.15%
+75.15%
1 Year
+2204.94%
+2204.94%

More News

Read More
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 9/12
Via Investor Brand Network
Analyst Ratings for Cabaletta Bio
Via Benzinga
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/23
Via Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 8/18
Via Investor Brand Network
HC Wainwright & Co. Maintains Buy Rating for Cabaletta Bio: Here's What You Need To Know
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
Via Benzinga
The 7 Most Promising Momentum Stocks to Own Now
Via InvestorPlace
Why Shares of Cabaletta Bio Are Up Tuesday
Via The Motley Fool
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/18
Via Investor Brand Network
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 7/12
Via Investor Brand Network
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio and WuXi Advanced Therapies Announce Expansion of GMP Manufacturing Agreement to Include CABA-201
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
From Cabaletta Bio
Via GlobeNewswire
Cabaletta Bio Appoints Global Commercial Leader Shawn Tomasello to Board of Directors
From Cabaletta Bio
Via GlobeNewswire
Analyst Sees Positive Outlook For Cabaletta Bio: Sees Promise In CAR-T Therapy Approach
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
Via Benzinga
SPOT Stock Alert: Spotify Moves on Analyst Upgrade
Via InvestorPlace
Why Is Cabaletta Bio (CABA) Stock Down 8% Today?
Via InvestorPlace
Why Advanced Health Intelligence Shares Are Trading Higher By 111%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.